Keyphrases
Bacteremia
100%
Acinetobacter Baumannii (A. baumannii)
100%
Mortality Factors
100%
7-day Mortality
100%
Carbapenem-resistant Acinetobacter Baumannii
100%
Oncology Patients
66%
Risk Factors
33%
Multivariate Analysis
33%
High Mortality
33%
Absolute Neutrophil Count
33%
Severity Score
33%
Infection Severity
33%
Infection Control Measures
33%
Appropriate Antibiotic Therapy
33%
SOFA Score
33%
Rational Antibiotic Use
33%
Antimicrobial Stewardship
33%
Thirty-day Mortality
33%
Dismal Prognosis
33%
Patients with Hematological Malignancies
33%
Community-acquired Bloodstream Infection
33%
Medicine and Dentistry
Retrospective Study
100%
Bacteremia
100%
Acinetobacter Baumannii
100%
Carbapenem
75%
Infection
50%
Antibiotic Therapy
50%
Antiinfective Agent
25%
Hematologic Malignancy
25%
Multivariate Analysis
25%
Bloodstream Infection
25%
Absolute Neutrophil Count
25%
SOFA Score
25%
Infection Control
25%
Pharmacology, Toxicology and Pharmaceutical Science
Retrospective Study
100%
Bacteremia
100%
Acinetobacter Baumannii
100%
Infection
75%
Carbapenem
75%
Antibiotic Therapy
50%
Antiinfective Agent
25%
Bloodstream Infection
25%
Hematologic Malignancy
25%
Nursing and Health Professions
Carbapenem
100%
Bacteremia
100%
Infection
66%
Antibiotic Therapy
66%
Infection Control
33%
Sequential Organ Failure Assessment Score
33%
Neutrophil Count
33%
Hematologic Malignancy
33%
Bloodstream Infection
33%
Antimicrobial Stewardship
33%
Multivariate Analysis
33%